Catalyst Pharmaceuticals
CPRX
₹2,208
Share price
-0.08%
Change (1 day)
66.86%
Change (1 year)
Categories
P/S ratio for Catalyst Pharmaceuticals (CPRX)
P/S ratio as of March 2025 (TTM): 6.36
According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.30. At the end of 2024 the company had a P/S ratio of 5.21.
P/S ratio history for Catalyst Pharmaceuticals from 2010 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 5.21 | 15.71% |
| 2023 | 4.50 | -50.2% |
| 2022 | 9.04 | 82.53% |
| 2021 | 4.95 | 70.08% |
| 2020 | 2.91 | -23.19% |
| 2019 | 3.79 | -99.04% |
| 2018 | 395 | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | -100% |
| 2010 | 39.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 4.81 | -24.30% | 🇺🇸 USA |
 | 3.89 | -38.75% | 🇺🇸 USA |
 | 4.37 | -31.28% | 🇺🇸 USA |
 | 0.0071 | -99.89% | 🇺🇸 USA |
 | 2.28 | -64.18% | 🇺🇸 USA |
 | 5.19 | -18.32% | 🇺🇸 USA |